Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|April 24, 2016
Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapyKakoli Mukherjee, Naibedya Chattopadhyay
Microbiology (Reading, England)|July 9, 2002
Proteins released during high toxin production in Clostridium difficileKakoli Mukherjee, Sture Karlsson, Lars G Burman, et al.
Infection and Immunity|March 26, 2003
Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperatureSture Karlsson, Bruno Dupuy, Kakoli Mukherjee, et al.
The Journal of Biological Chemistry|May 11, 2013
Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis pantothenate kinaseChristofer Björkelid, Terese Bergfors, Anand Kumar V Raichurkar, et al.
Microbiology (Reading, England)|June 26, 2010
Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosisDisha Awasthy, Anisha Ambady, Jyothi Bhat, et al.
Journal of Biomolecular Screening|October 11, 2014
Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPaseVaishali Humnabadkar, Prashanti Madhavapeddi, Halesha Basavarajappa, et al.
Journal of Biomolecular Screening|November 17, 2011
Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA)Janani Venkatraman, Jyothi Bhat, Suresh M Solapure, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead seriesSreekanth Ramachandran, Manoranjan Panda, Kakoli Mukherjee, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2006
Peptide deformylase inhibitors as potent antimycobacterial agentsJeanette W P Teo, Pamela Thayalan, David Beer, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2022
Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimizationBrahmam Pujala, Sreekanth A Ramachandran, Mukesh Sonawane, et al.
Pageof 2